Merck stock plunges after FDA rejects key cholesterol drug
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Merck stock plunges after FDA rejects key cholesterol drug
29 Apr 08, 18:56
NEW YORK (Associated Press) - Stock in drugmaker Merck & Co. plunged as analysts warned investors Tuesday to expect lower revenues and share prices, ...
more

 

 
© 2007 nafdacnigeria.org